Paul Hofman Selected Research

Paul Hofman Research Topics

Disease

121	Neoplasms (Cancer) 05/2024 - 09/2003
54	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 11/2013
38	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2009
19	Adenocarcinoma of Lung 01/2023 - 10/2010
18	Melanoma (Melanoma, Malignant) 09/2023 - 05/2010
11	Circulating Neoplastic Cells 12/2022 - 02/2011
11	Hypoxia (Hypoxemia) 01/2022 - 04/2011
10	COVID-19 10/2023 - 12/2020
10	Infections 12/2022 - 02/2004
10	Carcinoma (Carcinomatosis) 01/2022 - 11/2009
8	Papillary Thyroid Cancer 05/2014 - 11/2009
7	Carcinogenesis 05/2024 - 03/2006
7	Inflammation (Inflammations) 01/2024 - 08/2009
7	Neoplasm Metastasis (Metastasis) 02/2023 - 06/2014
7	Crohn Disease (Crohn's Disease) 11/2022 - 12/2007
6	Thyroid Neoplasms (Thyroid Cancer) 05/2016 - 06/2006
5	Adenocarcinoma 04/2022 - 11/2009
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018 - 01/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 11/2022 - 01/2013
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 02/2002
4	Tuberculosis (Tuberculoses) 12/2006 - 06/2003
3	Disease Progression 03/2024 - 12/2020
3	Uveal melanoma 12/2023 - 01/2021
3	Squamous Cell Carcinoma of Head and Neck 11/2022 - 01/2017
3	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2011
3	Malignant Mesothelioma 01/2020 - 10/2018
3	Colitis 10/2013 - 03/2003
2	Pneumonia (Pneumonitis) 01/2024 - 01/2007
2	Lung Diseases (Lung Disease) 01/2024 - 05/2019
2	Lymphoma (Lymphomas) 06/2023 - 11/2013
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2023 - 01/2021
2	Epilepsy (Aura) 03/2023 - 02/2004
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 06/2011
2	Communicable Diseases (Infectious Diseases) 12/2020 - 10/2004
2	Pleural Effusion (Pleural Effusions) 10/2018 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 07/2018 - 02/2013
2	Nevus (Nevi) 01/2017 - 01/2016
2	Insulin Resistance 09/2014 - 01/2006

Drug/Important Bio-Agent (IBA)

49	Biomarkers (Surrogate Marker)IBA 05/2024 - 02/2011
24	Immune Checkpoint InhibitorsIBA 05/2024 - 05/2016
21	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2007
15	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 12/2006
12	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2009
10	Formaldehyde (Formol)FDA Link 09/2023 - 06/2003
9	ParaffinIBA 09/2023 - 06/2003
9	RNA (Ribonucleic Acid)IBA 09/2023 - 09/2015
7	Tyrosine Kinase InhibitorsIBA 09/2023 - 12/2017
5	Cell-Free Nucleic AcidsIBA 01/2024 - 11/2014
5	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2023 - 11/2013
5	Insulin (Novolin)FDA Link 01/2022 - 11/2011
5	AntibodiesIBA 01/2021 - 10/2010
4	Mitogen-Activated Protein KinasesIBA 10/2023 - 03/2006
4	ErbB Receptors (EGF Receptor)IBA 03/2023 - 11/2009
4	pembrolizumabIBA 09/2022 - 01/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2008
4	Adenosine Triphosphate (ATP)IBA 12/2021 - 04/2012
4	Anaplastic Lymphoma KinaseIBA 06/2021 - 07/2015
4	Nucleic AcidsIBA 06/2021 - 12/2016
4	Monoclonal AntibodiesIBA 01/2021 - 10/2003
4	VimentinIBA 10/2011 - 08/2006
3	Oxygen (Dioxygen)IBA 10/2023 - 04/2012
3	Purinergic Receptors (Receptors, Purine)IBA 05/2023 - 03/2015
3	Phosphotransferases (Kinase)IBA 11/2022 - 11/2013
3	B7-H1 AntigenIBA 06/2022 - 01/2018
3	Eosine Yellowish-(YS) (Eosin)IBA 03/2022 - 02/2004
3	Indicators and Reagents (Reagents)IBA 12/2021 - 12/2016
3	Long Noncoding RNAIBA 01/2021 - 01/2019
3	NivolumabIBA 11/2020 - 01/2017
3	Circulating Tumor DNAIBA 11/2018 - 11/2014
3	CollagenIBA 01/2018 - 06/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 12/2007
2	COVID-19 VaccinesIBA 10/2023 - 12/2022
2	VaccinesIBA 10/2023 - 12/2022
2	Interleukin-18 (Interleukin 18)IBA 05/2023 - 01/2021
2	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2023 - 01/2022
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2023 - 10/2021
2	EnzymesIBA 01/2023 - 12/2018
2	Messenger RNA (mRNA)IBA 12/2022 - 10/2018
2	Hematoxylin (Haematoxylon)IBA 03/2022 - 12/2006
2	Voltage-Dependent Anion Channel 1IBA 01/2022 - 05/2015
2	Vorinostat FDA Link 04/2021 - 12/2011
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 12/2020
2	atezolizumabIBA 09/2020 - 10/2017
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2014
2	AsbestosIBA 10/2019 - 10/2018
2	N 30IBA 01/2018 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 01/2014
2	Fibronectins (Fibronectin)IBA 01/2017 - 05/2010
2	CrizotinibIBA 07/2015 - 11/2013
2	CytokinesIBA 03/2015 - 04/2003
2	Adenosine Triphosphatases (ATPase)IBA 07/2013 - 10/2012
2	Interleukin-8 (Interleukin 8)IBA 01/2012 - 05/2010

Therapy/Procedure

64	Therapeutics 03/2024 - 02/2004
33	Immunotherapy 03/2024 - 04/2016
18	Drug Therapy (Chemotherapy) 03/2024 - 04/2012
11	Precision Medicine 01/2021 - 11/2014
6	Radiotherapy 03/2024 - 09/2003
3	Highly Active Antiretroviral Therapy (HAART) 12/2006 - 09/2005
2	Molecular Targeted Therapy 10/2023 - 02/2019
2	Contraindications 01/2017 - 02/2004